Caerus Investment Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,350
Closed -$214K 41
2023
Q3
$214K Buy
+15,350
New +$196K 0.22% 30
2022
Q4
Sell
-15,350
Closed -$201K 57
2022
Q3
$201K Hold
15,350
0.25% 56
2022
Q2
$214K Buy
+15,350
New +$205K 0.26% 58

Other funds holding SBRA

Caerus Investment Advisors's SBRA Position: Q4 2023 in Review

Caerus Investment Advisors sold out of Sabra Healthcare REIT (SBRA) in Q4 2023, closing a stake of 15,350 shares — an estimated $214K sold.

Caerus Investment Advisors first reported a position in SBRA in Q2 2022 and held it in 3 quarters. The position peaked at $214K in Q2 2022. 359 funds tracked by Wall St. Rank hold SBRA as of Q4 2023.

  • Caerus Investment Advisors reported no remaining Sabra Healthcare REIT position as of Q4 2023 after selling out during the quarter.
  • Caerus Investment Advisors sold 15,350 Sabra Healthcare REIT shares in Q4 2023, an estimated $214K.
  • Caerus Investment Advisors first reported a position in Sabra Healthcare REIT in Q2 2022 and held it in 3 quarters.
  • Caerus Investment Advisors's Sabra Healthcare REIT position peaked at $214K in Q2 2022.
  • 359 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2023.

Based on Caerus Investment Advisors's 13F filing for Q4 2023, filed 19 Jan 2024.